The concomitant use of oxycodone HCl with all cytochrome P450 3A4 inhibitors may perhaps cause a rise in oxycodone plasma concentrations, which could increase or extend adverse reactions and will induce possibly lethal respiratory despair. Additionally, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may perhaps end in an increa